© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
January 18, 2021
Is the purported “saddest day of the year” evidence-based?
The Department of Health and Human Services moves to reduce administrative procedural barriers to OUD treatment.
Researchers have discovered a gene signaling pathway associated with a higher risk for developing schizophrenia.
January 15, 2021
Improving physical activity levels and eating habits could help patients with schizophrenia.
In an ADAPT-2 study, a combination of injectable naltrexone and oral bupropion showed promise for methamphetamine users.
January 08, 2021
The RISE study results look promising.
Major psychiatry organizations condemn the actions and events of January 6th.
January 06, 2021
A new formulation of dexmedetomidine meets primary and secondary endpoints in recently completed study.
January 04, 2021
A new phase 3 trial recently started for the novel treatment troriluzole.
December 23, 2020
New developments in Alzheimer disease treatment and research.